What smart money is saying about Lantheus Holdings Inc
LNTH
No fund has written a full thesis on Lantheus Holdings Inc in our archive, but 1 fund letter reports a position in it — most recently Brown Advisory U.S. Small-Cap Blend UCITS Fund in March 2026.
1
Reported positions
1
Bought
0
Sold
1
Letter
Position history
Every position in Lantheus Holdings Inc on record in the archive was reported in Q1 2026, across 1 fund letter — 1 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q1 2026 | 1 | 1 | 0 | 0 |
Fund activity · 1 position · 1 move
- March 2026
“Shares of Lantheus Holdings Inc (LNTH) were added after the company received FDA approval of its key product TruVu, positively shifting competitive positioning and allowing more confident underwriting of the operational outlook.”
Read the letterLantheus Holdings Inc
Read the letters behind these Lantheus Holdings Inc positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger